Tanaka, Y <br/><br/>
Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients.  [electronic resource] 

 -  Transplantation proceedings  Mar 2012 
 - 555-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2012.01.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Bacterial Infections--immunology<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Chi-Square Distribution<br/>Communicable Diseases--immunology<br/>Drug Monitoring--methods<br/>Drug Therapy, Combination<br/>Female<br/>Flow Cytometry<br/>Fluoresceins<br/>Fluorescent Dyes<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Japan<br/>Liver Transplantation--adverse effects<br/>Living Donors<br/>Logistic Models<br/>Lymphocyte Culture Test, Mixed<br/>Male<br/>Middle Aged<br/>Monitoring, Immunologic--methods<br/>Multivariate Analysis<br/>Mycoses--immunology<br/>Predictive Value of Tests<br/>Risk Assessment<br/>Risk Factors<br/>Succinimides<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Virus Diseases--immunology